Saphnelo 300 mg/2 mL (150 mg/mL) injection Images

Generic Name: anifrolumab

This medication has been identified as Saphnelo 300 mg/2 mL (150 mg/mL) injection. It is supplied by AstraZeneca.

Saphnelo is used in the treatment of Lupus and belongs to the drug class selective immunosuppressants. Saphnelo 300 mg/2 mL (150 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Saphnelo

Generic Name

anifrolumab

Strength

300 mg/2 mL (150 mg/mL) injection

Availability

Prescription only

Drug Class

Selective immunosuppressants

CSA Schedule

Not a controlled drug

Labeler / Supplier

AstraZeneca

National Drug Code (NDC)

00310-3040

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer